Clinical Research Directory
Browse clinical research sites, groups, and studies.
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
Sponsor: First People's Hospital of Hangzhou
Summary
Herpes Zoster (HZ), caused by the Varicella-Zoster Virus (VZV), is a common infection characterized by localized pain and blistering, with higher incidence in females. HZ affects patients' physical health, mental well-being, and quality of life. The immune system is critical in HZ pathogenesis. Studies show acupuncture relieves pain, modulates immunity, and may lower postherpetic neuralgia (PHN) risk. However, evidence is limited on whether electroacupuncture (EA) alleviates HZ by modulating immune cells. Using mass cytometry (CyTOF), this study will analyze peripheral immune cell changes pre- and post-EA to explore its regulatory effects on HZ immunity. This study will recruit HZ patients and healthy controls (HC), dividing patients into medication-only and medication+EA groups to assess EA's potential immunomodulatory effects in HZ treatment.
Official title: The Regulatory Mechanisms of Electroacupuncture Intervention on Immune Cells in Herpes Zoster
Key Details
Gender
FEMALE
Age Range
50 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2024-11-11
Completion Date
2027-12-31
Last Updated
2026-02-03
Healthy Volunteers
Yes
Conditions
Interventions
Drug
1\) Valacyclovir Hydrochloride tablets, 0.3 g per dose, twice daily; 2) Mecobalamin tablets, 0.5 mg, three times daily. Taken continuously for 7 days.The affected skin is kept clean and protected to maintain lesion integrity.
Electroacupuncture
Electroacupuncture Treatment: Needling acupoints include the Jiaji points corresponding to the spinal nerve segment of the affected area, Ashi acupoints along the affected zone, and bilateral Hegu and Waiguan points. Electroacupuncture will be performed once daily for 30 minutes per session, with a total of 7 consecutive sessions. The Jiaji and Ashi acupoints will be connected to an electroacupuncture device, set to disperse-dense wave stimulation at a frequency of 2/100 Hz, with current intensity adjusted to the patient's tolerance level.
Locations (1)
The Affiliated Hangzhou First People's Hospital
Hangzhou, Zhejiang, China